ID CKLF4_HUMAN Reviewed; 234 AA. AC Q8IZR5; Q52M40; Q8IZR4; Q8IZV1; DT 19-SEP-2003, integrated into UniProtKB/Swiss-Prot. DT 01-MAR-2003, sequence version 1. DT 24-JAN-2024, entry version 140. DE RecName: Full=CKLF-like MARVEL transmembrane domain-containing protein 4; DE AltName: Full=Chemokine-like factor superfamily member 4; GN Name=CMTM4 {ECO:0000312|HGNC:HGNC:19175}; Synonyms=CKLFSF4; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 3). RC TISSUE=Kidney; RA Ding P., Han W., Shi S., Yang T., Song Q., Zhang Y., Ma D.; RL Submitted (JUN-2002) to the EMBL/GenBank/DDBJ databases. RN [2] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND TISSUE SPECIFICITY. RC TISSUE=Spleen; RX PubMed=12782130; DOI=10.1016/s0888-7543(03)00095-8; RA Han W., Ding P., Xu M., Wang L., Rui M., Shi S., Liu Y., Zheng Y., Chen Y., RA Yang T., Ma D.; RT "Identification of eight genes encoding chemokine-like factor superfamily RT members 1-8 (CKLFSF1-8) by in silico cloning and experimental validation."; RL Genomics 81:609-617(2003). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2). RC TISSUE=Liver; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [4] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=21269460; DOI=10.1186/1752-0509-5-17; RA Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., RA Bennett K.L., Superti-Furga G., Colinge J.; RT "Initial characterization of the human central proteome."; RL BMC Syst. Biol. 5:17-17(2011). RN [5] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-194, AND IDENTIFICATION BY RP MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Cervix carcinoma, and Erythroleukemia; RX PubMed=23186163; DOI=10.1021/pr300630k; RA Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J., RA Mohammed S.; RT "Toward a comprehensive characterization of a human cancer cell RT phosphoproteome."; RL J. Proteome Res. 12:260-271(2013). RN [6] RP FUNCTION, INTERACTION WITH PD-L1/CD274 AND CMTM6, AND IDENTIFICATION BY RP MASS SPECTROMETRY. RX PubMed=28813410; DOI=10.1038/nature23669; RA Mezzadra R., Sun C., Jae L.T., Gomez-Eerland R., de Vries E., Wu W., RA Logtenberg M.E.W., Slagter M., Rozeman E.A., Hofland I., Broeks A., RA Horlings H.M., Wessels L.F.A., Blank C.U., Xiao Y., Heck A.J.R., Borst J., RA Brummelkamp T.R., Schumacher T.N.M.; RT "Identification of CMTM6 and CMTM4 as PD-L1 protein regulators."; RL Nature 549:106-110(2017). CC -!- FUNCTION: Acts as a backup for CMTM6 to regulate plasma membrane CC expression of PD-L1/CD274, an immune inhibitory ligand critical for CC immune tolerance to self and antitumor immunity. May protect PD- CC L1/CD274 from being polyubiquitinated and targeted for degradation. CC {ECO:0000269|PubMed:28813410}. CC -!- SUBUNIT: Interacts with PD-L1/CD274 and CMTM6. CC {ECO:0000269|PubMed:28813410}. CC -!- INTERACTION: CC Q8IZR5; Q9NZQ7: CD274; NbExp=3; IntAct=EBI-3925367, EBI-4314282; CC Q8IZR5-2; P06727: APOA4; NbExp=3; IntAct=EBI-17278014, EBI-1222447; CC Q8IZR5-2; Q8NI60: COQ8A; NbExp=3; IntAct=EBI-17278014, EBI-745535; CC Q8IZR5-2; Q9BY27: DGCR6L; NbExp=3; IntAct=EBI-17278014, EBI-742953; CC Q8IZR5-2; Q9NR28: DIABLO; NbExp=3; IntAct=EBI-17278014, EBI-517508; CC Q8IZR5-2; C9JCN9: HSBP1L1; NbExp=3; IntAct=EBI-17278014, EBI-2685549; CC Q8IZR5-2; Q504T8: MIDN; NbExp=3; IntAct=EBI-17278014, EBI-7153979; CC Q8IZR5-2; Q96AL5: PBX3; NbExp=3; IntAct=EBI-17278014, EBI-741171; CC Q8IZR5-2; P43378: PTPN9; NbExp=3; IntAct=EBI-17278014, EBI-742898; CC Q8IZR5-2; Q9H0W8: SMG9; NbExp=3; IntAct=EBI-17278014, EBI-2872322; CC Q8IZR5-2; Q13596: SNX1; NbExp=3; IntAct=EBI-17278014, EBI-2822329; CC Q8IZR5-2; Q9NZD8: SPG21; NbExp=3; IntAct=EBI-17278014, EBI-742688; CC Q8IZR5-2; Q99909: SSX3; NbExp=3; IntAct=EBI-17278014, EBI-10295431; CC Q8IZR5-2; P49675: STAR; NbExp=3; IntAct=EBI-17278014, EBI-722932; CC Q8IZR5-2; Q969Z0: TBRG4; NbExp=3; IntAct=EBI-17278014, EBI-702328; CC Q8IZR5-2; Q15560: TCEA2; NbExp=3; IntAct=EBI-17278014, EBI-710310; CC Q8IZR5-2; P49638: TTPA; NbExp=3; IntAct=EBI-17278014, EBI-10210710; CC Q8IZR5-2; Q9BQ24: ZFYVE21; NbExp=3; IntAct=EBI-17278014, EBI-2849569; CC -!- SUBCELLULAR LOCATION: Membrane {ECO:0000255}; Multi-pass membrane CC protein {ECO:0000255}. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=3; CC Name=1; CC IsoId=Q8IZR5-1; Sequence=Displayed; CC Name=2; CC IsoId=Q8IZR5-2; Sequence=VSP_008261; CC Name=3; CC IsoId=Q8IZR5-3; Sequence=VSP_008260, VSP_008261; CC -!- TISSUE SPECIFICITY: Highly expressed in testis and prostate. CC {ECO:0000269|PubMed:12782130}. CC -!- SIMILARITY: Belongs to the chemokine-like factor family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AF521889; AAN73845.1; -; mRNA. DR EMBL; AF521890; AAN73846.1; -; mRNA. DR EMBL; AF479814; AAN73436.1; -; mRNA. DR EMBL; BC093679; AAH93679.1; -; mRNA. DR CCDS; CCDS10817.1; -. [Q8IZR5-1] DR CCDS; CCDS42170.1; -. [Q8IZR5-2] DR RefSeq; NP_848933.1; NM_178818.2. [Q8IZR5-1] DR RefSeq; NP_852662.1; NM_181521.2. [Q8IZR5-2] DR RefSeq; XP_011521184.1; XM_011522882.1. [Q8IZR5-3] DR AlphaFoldDB; Q8IZR5; -. DR SMR; Q8IZR5; -. DR BioGRID; 126972; 35. DR IntAct; Q8IZR5; 30. DR STRING; 9606.ENSP00000333833; -. DR TCDB; 1.A.64.4.4; the plasmolipin (plasmolipin) family. DR iPTMnet; Q8IZR5; -. DR PhosphoSitePlus; Q8IZR5; -. DR SwissPalm; Q8IZR5; -. DR BioMuta; CMTM4; -. DR DMDM; 34921813; -. DR EPD; Q8IZR5; -. DR jPOST; Q8IZR5; -. DR MassIVE; Q8IZR5; -. DR MaxQB; Q8IZR5; -. DR PaxDb; 9606-ENSP00000333833; -. DR PeptideAtlas; Q8IZR5; -. DR ProteomicsDB; 71410; -. [Q8IZR5-1] DR ProteomicsDB; 71411; -. [Q8IZR5-2] DR ProteomicsDB; 71412; -. [Q8IZR5-3] DR Pumba; Q8IZR5; -. DR Antibodypedia; 15544; 170 antibodies from 26 providers. DR DNASU; 146223; -. DR Ensembl; ENST00000330687.8; ENSP00000333833.4; ENSG00000183723.13. [Q8IZR5-1] DR Ensembl; ENST00000394106.7; ENSP00000377666.2; ENSG00000183723.13. [Q8IZR5-2] DR Ensembl; ENST00000563952.1; ENSP00000456380.1; ENSG00000183723.13. [Q8IZR5-3] DR GeneID; 146223; -. DR KEGG; hsa:146223; -. DR MANE-Select; ENST00000394106.7; ENSP00000377666.2; NM_181521.3; NP_852662.1. [Q8IZR5-2] DR UCSC; uc002epz.3; human. [Q8IZR5-1] DR AGR; HGNC:19175; -. DR CTD; 146223; -. DR DisGeNET; 146223; -. DR GeneCards; CMTM4; -. DR HGNC; HGNC:19175; CMTM4. DR HPA; ENSG00000183723; Low tissue specificity. DR MIM; 607887; gene. DR neXtProt; NX_Q8IZR5; -. DR OpenTargets; ENSG00000183723; -. DR PharmGKB; PA38814; -. DR VEuPathDB; HostDB:ENSG00000183723; -. DR eggNOG; KOG4788; Eukaryota. DR GeneTree; ENSGT00940000159573; -. DR HOGENOM; CLU_104458_0_0_1; -. DR InParanoid; Q8IZR5; -. DR OMA; SFICIET; -. DR OrthoDB; 5359001at2759; -. DR PhylomeDB; Q8IZR5; -. DR TreeFam; TF317387; -. DR PathwayCommons; Q8IZR5; -. DR SignaLink; Q8IZR5; -. DR BioGRID-ORCS; 146223; 15 hits in 1154 CRISPR screens. DR ChiTaRS; CMTM4; human. DR GenomeRNAi; 146223; -. DR Pharos; Q8IZR5; Tbio. DR PRO; PR:Q8IZR5; -. DR Proteomes; UP000005640; Chromosome 16. DR RNAct; Q8IZR5; Protein. DR Bgee; ENSG00000183723; Expressed in secondary oocyte and 189 other cell types or tissues. DR ExpressionAtlas; Q8IZR5; baseline and differential. DR GO; GO:0016020; C:membrane; IEA:UniProtKB-SubCell. DR InterPro; IPR008253; Marvel. DR PANTHER; PTHR22776:SF29; CKLF-LIKE MARVEL TRANSMEMBRANE DOMAIN-CONTAINING PROTEIN 4; 1. DR PANTHER; PTHR22776; MARVEL-CONTAINING POTENTIAL LIPID RAFT-ASSOCIATED PROTEIN; 1. DR Pfam; PF01284; MARVEL; 1. DR PROSITE; PS51225; MARVEL; 1. DR Genevisible; Q8IZR5; HS. PE 1: Evidence at protein level; KW Alternative splicing; Membrane; Phosphoprotein; Reference proteome; KW Transmembrane; Transmembrane helix. FT CHAIN 1..234 FT /note="CKLF-like MARVEL transmembrane domain-containing FT protein 4" FT /id="PRO_0000186103" FT TRANSMEM 59..79 FT /note="Helical" FT /evidence="ECO:0000255" FT TRANSMEM 85..105 FT /note="Helical" FT /evidence="ECO:0000255" FT TRANSMEM 123..143 FT /note="Helical" FT /evidence="ECO:0000255" FT TRANSMEM 151..171 FT /note="Helical" FT /evidence="ECO:0000255" FT DOMAIN 49..176 FT /note="MARVEL" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00581" FT REGION 1..38 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 14..35 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT MOD_RES 194 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:23186163" FT VAR_SEQ 34..62 FT /note="Missing (in isoform 3)" FT /evidence="ECO:0000303|Ref.1" FT /id="VSP_008260" FT VAR_SEQ 209..234 FT /note="Missing (in isoform 2 and isoform 3)" FT /evidence="ECO:0000303|PubMed:12782130, FT ECO:0000303|PubMed:15489334, ECO:0000303|Ref.1" FT /id="VSP_008261" SQ SEQUENCE 234 AA; 25828 MW; 629B5CCEE873C895 CRC64; MRSGEELDGF EGEASSTSMI SGASSPYQPT TEPVSQRRGL AGLRCDPDYL RGALGRLKVA QVILALIAFI CIETIMACSP CEGLYFFEFV SCSAFVVTGV LLIMFSLNLH MRIPQINWNL TDLVNTGLSA FLFFIASIVL AALNHRAGAE IAAVIFGFLA TAAYAVNTFL AVQKWRVSVR QQSTNDYIRA RTESRDVDSR PEIQRLDTFS YSTNVTVRKK SPTNLLSLNH WQLA //